Patient Compliance

But study shows risk was better than expected-so expanded-criteria organs might be 'only marginally worse' than standard

First-born more likely to be food-allergic than younger siblings

Real-world outcomes with investigational drug still favourable

But oral therapy associated with more frequent adverse events

New treatment is effective in Canada and U.S., but not in rest of North America; epilepsy classification may have been a factor

The new drug safinamide might have some impact in preventing the involuntary movements characteristic of Parkinson's disease. However, it did not perform any better than placebo over a two-year period.

Study shows it's safe and can desensitize, but response range is wide

Indicated for use in combination with metformin and/or a sulfonylurea to improve glycemic control in adults with type 2 diabetes.

Leading researchers are optimistic, but evidence is still too preliminary

Work on Ontario's fourth and largest diagnostic imaging repository is underway and will begin benefitting patients across the western parts of the Greater Toronto Area and North Simcoe Muskoka later this year.